Cargando…
Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
In the early years of the highly active antiretroviral therapy (HAART) era, HIV with resistance to two or more agents in different antiretroviral classes posed a significant clinical challenge. Multidrug-resistant (MDR) HIV was an important cause of treatment failure, morbidity, and mortality. Treat...
Autores principales: | Harris, Marianne, Nosyk, Bohdan, Harrigan, Richard, Lima, Viviane Dias, Cohen, Calvin, Montaner, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502757/ https://www.ncbi.nlm.nih.gov/pubmed/23193464 http://dx.doi.org/10.1155/2012/595762 |
Ejemplares similares
-
Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy
por: Lima, Viviane D., et al.
Publicado: (2012) -
The Evolving Landscape of the Economics of HIV Treatment and Prevention
por: Nosyk, Bohdan, et al.
Publicado: (2012) -
High Levels of Heterogeneity in the HIV Cascade of Care across Different Population Subgroups in British Columbia, Canada
por: Lourenço, Lillian, et al.
Publicado: (2014) -
Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
por: Enns, Benjamin, et al.
Publicado: (2019) -
Disparities in the Burden of HIV/AIDS in Canada
por: Hogg, Robert S., et al.
Publicado: (2012)